Nova Biomedical opens new subsidiary in Brazil

Nova Biomedical recently announced the opening of a new sales, service, manufacturing, and distribution subsidiary in Brazil. The new facility demonstrates Nova’s commitment to the Brazilian market and to supporting the strong growth of in vitro diagnostic testing in Brazil and Mercosur countries. Located in the town of Nova Lima, a suburb of the city of Belo Horizonte in the state of Minas Gerais, Nova’s new subsidiary is designed to fully support current business and to allow for anticipated future growth. The new subsidiary provides full sales and service support, inventory warehousing and distribution, and manufacturing for Nova customers in Brazil. With the new subsidiary, Nova brings the most advanced technology whole blood analysers for hospital and point-of-care (POC) use to Brazil. The Stat Profile Prime line of hospital analysers includes the Critical Care System (CCS), Electrolyte System (ES), and Prime Plus, which all feature Prime’s innovative, no-maintenance cartridge and reagent technology that saves time and space, and reduces costs. Prime CCS offers a comprehensive testing menu of pH, PCO2, PO2, Hct, Na, K, Cl, iCa, Glu, and Lac. Prime ES provides comprehensive electrolyte testing with Na, K, Cl, iCa, and iMg. Results are ready for both devices in only 60 seconds from 100 microliters of whole blood. Prime Plus combines blood gas, electrolyte, and metabolite testing with co-oximetry, for an extensive, 22-test menu that’s ready in only 60 seconds. The Stat Profile pHOx Ultra analyser provides up to 20 critical care tests from 210 microliters in only two minutes, with other partial test panels available in less than one minute. The StatStrip and StatSensor line of handheld, POC meter and test strip analysers provide rapid glucose/ketone, lactate, and creatinine results at the bedside to support clinical decision making. “We, at Nova Biomedical, are excited to welcome our new Brazilian subsidiary to our international team and for the opportunity to continue to bring Nova’s in vitro diagnostic testing technology to this important global market,” said Ken Lumm, Senior Director, International Sales at Nova.

http://www.novabio.us/